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Morphine induces dopamine release in the caudate putamen (CPu), which promotes 
stereotyped behavior and habit learning for drug-seeking and –taking. Nigrostriatal pathway 
stimulation by morphine is due to a removal of tonic inhibition arising from SNr GABA 
interneurons on SNc dopaminergic neurons through the mu opioid receptor (MOR). Long-
term morphine exposure produces a series of adaptations in SNc dopamine neurons, which 
affect neuron excitability and dopamine output to CPu. We have previously shown that 
dopamine D4 receptor (D4R) stimulation counteracts acute and chronic morphine-induced 
accumulation of several transcription factors in the CPu (Gago et al., 2011 Brain Res.). Since 
D4R is expressed in the SNr (Rivera et al., Brain Res. 2003), we postulate that a functional 
D4R-MOR interaction at the midbrain level could exists.  
We have investigated the role of D4R in the morphine-induced nigroestriatal 
dopamine metabolism in the rat brain using biochemical and immunohistochemical 
techniques. We also have studied the influence of D4R on morphine-induced morphological 
changes in SNc dopamine neurons using both immunohistochemical and image analysis 
techniques. Finally, we examined a possible underlying mechanism of the D4R-MOR 
interaction at the SN level using in vitro quantitative receptor autoradiography.  
 We have found that D4R activation restores dopamine metabolism in the nigroestriatal 
pathway after acute morphine treatment and prevents morphine-induced rise of tyroxine 
hydroxylase and dopamine transporter. Rats receiving a continuous treatment of morphine (6 
days) showed SNc dopamine neurons with smaller size and higher circularity index compared 
with the controls animals. These morphine-induced morphological adaptatives changes were 
prevented when a D4R agonist (PD168,077) was administered at the same time with 
morphine. Autoradiographic studies demonstrated that the D4R agonist reduce the affinity of 
MOR. The present study provides evidence for the existence of a fully blocking effect of the 
D4R on the activation of dopaminergic nigroestriatal pathway by morphine. 
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